Spinal Tumor Ablation and Vertebral Augmentation for Treatment of Pa…

Douglas Beall

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

Spine Ablation in 2023: Indications, Goals, Guidelines, Evidence, an…

Jason Levy

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

Overview and Updates in Brain Tumors

Henry Friedman

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Mohan

Best Practices for the Provider Approach in Treating Patients With I…

Katherine Peters

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Impact of Radiofrequency Ablation (RFA) on Spinal Tumors

International Society for the Advancement of Spine Surgery

B. Bennett

Updates on Glioblastoma

Dana-Farber Cancer Institute

D. Reardon

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

NCCN Guidelines on Utilizing Radio-Frequency Ablation to Treat Metas…

Jack William Jennings

Medical and Symptom Management of Patients With Brain Tumors

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

A. Pruitt

Overcoming Barriers to Extend Survival: Promising Results of Clinica…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Brem

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Trametinib …

Insights from 2023 ASCO® Annual Meeting

V. Subbiah

Seizure Management for Brain Tumor Survivors: Current Concepts

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Sinha

Surgical Approaches for Brain Tumors

Dana-Farber Cancer Institute

W. Linda Bi, O. Arnaout